Sanofi drug gets EU panel backing for progressive multiple sclerosis
The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of Sanofi's (EURONEXT: SAN) (NASDAQ: SNY) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
